Imamura H., Furukawa H. et al.: Phase II study of a new regimen for S-1　therapy aiming at adverse reaction mitigation for metastatic gastric　cancer: a study by the Osaka Gastrointestinal Chemotherapy Study Group　OGSG-0103. 41th Anual Meeting of American Society of Clinical Oncology Congress, Orlando, USA.